Bio-Rad Laboratories, Inc.’s BIO solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCR™ Replication ...

Bio-Rad’s QX600 ddPCR platform is currently robust and continues to expand. In the fourth quarter of 2024, the Droplet Digital PCR franchise grew by mid-single digits and was bolstered by ...

The Vericheck ddPCR Empty-Full Capsid Kit from Bio-Rad precisely measures DNA and protein in a single well using the unmatched precision of Droplet DigitalTM PCR (ddPCR). The entire adeno ...

The SARS-CoV-2 Droplet Digital PCR (ddPCR) test runs on Bio-Rad's QX200 and QXDx ddPCR systems. The high sensitivity of the test makes it well suited to screening upper respiratory samples in patients ...

Schwartz emphasized Bio-Rad's commitment to supporting customers ... including advancements in the Droplet Digital PCR (ddPCR) portfolio, and noted strong year-over-year growth in the process ...

Biodesix contributed data generated using Bio-Rad Droplet Digital™ PCR (ddPCR™) * technology to detect ctDNA from patient samples. “Biodesix is proud to be a partner on this important ...

Biodesix contributed data generated using Bio-Rad Droplet Digital™ PCR (ddPCR) * technology to detect ctDNA from patient samples. “Biodesix is proud to be a partner on this important project, which ...